
KOSS Valuation
Koss Corp
- Overview
- Forecast
- Valuation
- Earnings
KOSS Relative Valuation
KOSS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KOSS is overvalued; if below, it's undervalued.
Historical Valuation
Koss Corp (KOSS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Koss Corp (KOSS) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:5.76
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Koss Corp. (KOSS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Koss Corp. (KOSS) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Koss Corp. (KOSS) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Koss Corp. (KOSS) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Koss Corp. (KOSS) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Koss Corp (KOSS) has a current Price-to-Book (P/B) ratio of 1.74. Compared to its 3-year average P/B ratio of 1.55 , the current P/B ratio is approximately 12.54% higher. Relative to its 5-year average P/B ratio of 3.05, the current P/B ratio is about -43.06% higher. Koss Corp (KOSS) has a Forward Free Cash Flow (FCF) yield of approximately -0.66%. Compared to its 3-year average FCF yield of 7.39%, the current FCF yield is approximately -108.93% lower. Relative to its 5-year average FCF yield of 5.10% , the current FCF yield is about -112.94% lower.
1.74
P/B
Median3y
1.55
Median5y
3.05
-0.66
FCF Yield
Median3y
7.39
Median5y
5.10
Competitors Valuation Multiple
The average P/S ratio for KOSS's competitors is 3.27, providing a benchmark for relative valuation. Koss Corp Corp (KOSS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 5.44%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of KOSS decreased by 29.84% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 2.64M to 2.78M.
The secondary factor is the Margin Expansion, contributed -4.29%to the performance.
Overall, the performance of KOSS in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch

MATH
Metalpha Technology Holding Ltd
2.800
USD
0.00%

RVPH
Reviva Pharmaceuticals Holdings Inc
0.526
USD
-2.59%

FBLG
Fibrobiologics Inc
0.574
USD
0.00%

NEUE
NeueHealth Inc
6.560
USD
0.00%

VRCA
Verrica Pharmaceuticals Inc
5.960
USD
0.00%

CRT
Cross Timbers Royalty Trust
8.700
USD
+0.12%

IPWR
Ideal Power Inc
5.240
USD
0.00%

AIXI
Xiao-I Corp
1.510
USD
0.00%

NVA
Nova Minerals Ltd
11.500
USD
+0.52%

SOTK
Sono-Tek Corp
3.300
USD
0.00%
FAQ

Is Koss Corp (KOSS) currently overvalued or undervalued?
Koss Corp (KOSS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Koss Corp (KOSS) is between to according to relative valuation methord.

What is Koss Corp (KOSS) fair value?

How does KOSS's valuation metrics compare to the industry average?

What is the current P/B ratio for Koss Corp (KOSS) as of Aug 18 2025?

What is the current FCF Yield for Koss Corp (KOSS) as of Aug 18 2025?

What is the current Forward P/E ratio for Koss Corp (KOSS) as of Aug 18 2025?
